9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole
C48H39N5O — CID 171769181
Data last refreshed: (MolForge compound catalog, from PubChem)
About 9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole
9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole (PubChem CID 171769181) has the molecular formula C48H39N5O and a molecular weight of 701.87 g/mol. Its IUPAC name is 9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole.
Molecular Properties
| Compound Name | 9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole |
|---|---|
| PubChem CID | 171769181 |
| Molecular Formula | C48H39N5O |
| Molecular Weight | 701.87 g/mol |
| Exact Mass | 701.32 |
| IUPAC Name | 9-[2-[2-[3-(benzimidazol-1-yl)-5-tert-butylphenoxy]carbazol-9-yl]-4-pyridinyl]-1,8-dimethylcarbazole |
| SMILES | Cc1cccc2c3cccc(C)c3n(-c3ccnc(-n4c5ccccc5c5ccc(Oc6cc(-n7cnc8ccccc87)cc(C(C)(C)C)c6)cc54)c3)c12 |
| InChI | InChI=1S/C48H39N5O/c1-30-12-10-15-39-40-16-11-13-31(2)47(40)52(46(30)39)33-22-23-49-45(27-33)53-42-18-8-6-14-37(42)38-21-20-35(28-44(38)53)54-36-25-32(48(3,4)5)24-34(26-36)51-29-50-41-17-7-9-19-43(41)51/h6-29H,1-5H3 |
| InChIKey | YZNGACSLVLMQHS-UHFFFAOYSA-N |
| XLogP | 12.32 |
| TPSA | 49.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 701.87 |
| LogP ≤ 5 | 12.32 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171769181 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.